LT3455B - Intravaginal delivery system of active agent - Google Patents
Intravaginal delivery system of active agent Download PDFInfo
- Publication number
- LT3455B LT3455B LTIP1957A LTIP1957A LT3455B LT 3455 B LT3455 B LT 3455B LT IP1957 A LTIP1957 A LT IP1957A LT IP1957 A LTIP1957 A LT IP1957A LT 3455 B LT3455 B LT 3455B
- Authority
- LT
- Lithuania
- Prior art keywords
- active agent
- sleeve
- delivery system
- intravaginal
- agent delivery
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title claims abstract description 65
- 229920000642 polymer Polymers 0.000 claims abstract description 10
- 239000012528 membrane Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- -1 polysiloxane Polymers 0.000 claims description 15
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 11
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 11
- BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229920001971 elastomer Polymers 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 238000009792 diffusion process Methods 0.000 claims description 3
- 230000000757 progestagenic effect Effects 0.000 claims description 3
- 244000043261 Hevea brasiliensis Species 0.000 claims description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 2
- 229920005549 butyl rubber Polymers 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000806 elastomer Substances 0.000 claims description 2
- 239000000262 estrogen Substances 0.000 claims description 2
- 230000009245 menopause Effects 0.000 claims description 2
- 229920003052 natural elastomer Polymers 0.000 claims description 2
- 229920001194 natural rubber Polymers 0.000 claims description 2
- 229920001935 styrene-ethylene-butadiene-styrene Polymers 0.000 claims description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 2
- 229920002397 thermoplastic olefin Polymers 0.000 claims description 2
- 229920005992 thermoplastic resin Polymers 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 239000011149 active material Substances 0.000 claims 1
- 238000007664 blowing Methods 0.000 claims 1
- 238000001794 hormone therapy Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 description 22
- 229940079593 drug Drugs 0.000 description 21
- 230000008878 coupling Effects 0.000 description 14
- 238000010168 coupling process Methods 0.000 description 14
- 238000005859 coupling reaction Methods 0.000 description 14
- 239000011159 matrix material Substances 0.000 description 11
- 239000010410 layer Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229940124447 delivery agent Drugs 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960004400 levonorgestrel Drugs 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
- Paper (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
- Prostheses (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Particle Formation And Scattering Control In Inkjet Printers (AREA)
- Details Of Garments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI932789A FI95768C (fi) | 1993-06-17 | 1993-06-17 | Emättimensisäinen antosysteemi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LTIP1957A LTIP1957A (en) | 1995-01-31 |
| LT3455B true LT3455B (en) | 1995-10-25 |
Family
ID=8538154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTIP1957A LT3455B (en) | 1993-06-17 | 1994-06-16 | Intravaginal delivery system of active agent |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5694947A (enExample) |
| EP (1) | EP0703802B1 (enExample) |
| JP (1) | JP3803714B2 (enExample) |
| KR (1) | KR100312764B1 (enExample) |
| CN (1) | CN1126574C (enExample) |
| AT (1) | ATE177657T1 (enExample) |
| AU (1) | AU674758B2 (enExample) |
| BR (1) | BR9407118A (enExample) |
| CZ (1) | CZ284989B6 (enExample) |
| DE (1) | DE69417232T2 (enExample) |
| DK (1) | DK0703802T3 (enExample) |
| EE (1) | EE03202B1 (enExample) |
| ES (1) | ES2130423T3 (enExample) |
| FI (1) | FI95768C (enExample) |
| GR (1) | GR3030565T3 (enExample) |
| HU (1) | HU217950B (enExample) |
| LT (1) | LT3455B (enExample) |
| LV (1) | LV12452B (enExample) |
| MY (1) | MY113965A (enExample) |
| NO (1) | NO311498B1 (enExample) |
| PL (1) | PL176664B1 (enExample) |
| RU (1) | RU2121824C1 (enExample) |
| TW (1) | TW286273B (enExample) |
| WO (1) | WO1995000199A1 (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95768C (fi) * | 1993-06-17 | 1996-03-25 | Leiras Oy | Emättimensisäinen antosysteemi |
| GB9522403D0 (en) * | 1995-11-01 | 1996-01-03 | Hoechst Roussel Ltd | Intravaginal drug delivery device |
| US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
| DE69929055T2 (de) * | 1998-05-01 | 2006-07-20 | Duramed Pharmaceuticals Inc., Cincinnati | Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung |
| US6476079B1 (en) * | 1999-12-23 | 2002-11-05 | Leiras Oy | Devices for the delivery of drugs having antiprogestinic properties |
| GB0009914D0 (en) | 2000-04-20 | 2000-06-07 | Metris Therapeutics Limited | Device |
| WO2003017971A1 (en) * | 2001-08-31 | 2003-03-06 | Schering Oy | Drug delivery system |
| CN1822815B (zh) * | 2003-07-10 | 2012-04-11 | 沃纳奇尔科特(爱尔兰)有限公司 | 阴道内药物传递装置 |
| US7862552B2 (en) * | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| EP1906987B1 (en) | 2005-07-19 | 2011-01-19 | The Population Council, Inc. | Methods and compositions for emergency contraception using endothelin receptor antagonists |
| BRPI0709344A2 (pt) * | 2006-03-20 | 2011-07-12 | Duramed Pharmaceuticals Inc | anel intravaginal comprimido flexìvel, seu uso e processo de preparação, método de fornecer um agente ativo, kit terapêutico e produto |
| AU2007324588B2 (en) * | 2006-11-20 | 2012-09-13 | Intervet International B.V. | Helically-shaped drug delivery system |
| TW200927141A (en) * | 2007-11-22 | 2009-07-01 | Bayer Schering Pharma Oy | Vaginal delivery system |
| EP2062568A1 (en) * | 2007-11-22 | 2009-05-27 | Bayer Schering Pharma Oy | Vaginal delivery system |
| CN101977651A (zh) * | 2008-01-25 | 2011-02-16 | 犹他大学研究基金会 | 线性级释放聚合物 |
| EP2249757B1 (en) | 2008-02-04 | 2017-08-09 | Ferring B.V. | Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof |
| FI20095550A0 (fi) * | 2009-05-19 | 2009-05-19 | Bayer Schering Pharma Oy | Vaginaalinen antojärjestelmä |
| FI20095563A7 (fi) * | 2009-05-20 | 2010-11-21 | Bayer Schering Pharma Oy | Vaginaalinen antojärjestelmä |
| CN104887388B (zh) | 2009-06-03 | 2018-01-09 | 弗赛特影像5股份有限公司 | 前段药物输送 |
| DE102010003494A1 (de) * | 2010-03-31 | 2011-10-06 | Bayer Schering Pharma Aktiengesellschaft | Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose |
| US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
| EP2749286B1 (en) | 2011-08-26 | 2017-03-01 | Universidad De Santiago De Chile | Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process |
| GB201115592D0 (en) * | 2011-09-09 | 2011-10-26 | Vivosens Medical Gmbh | Flexible ring pessary |
| EP2755615B1 (en) | 2011-09-14 | 2022-04-06 | Forsight Vision5, Inc. | Ocular insert apparatus |
| CN103007427B (zh) * | 2011-09-21 | 2016-01-20 | 上海市计划生育科学研究所 | 缓控释宫内释药器及其制备方法 |
| EP2782584B1 (en) | 2011-11-23 | 2021-06-09 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP2641602A1 (en) | 2012-03-23 | 2013-09-25 | PregLem S.A. | Method for treating gynecological diseases |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| KR20150051234A (ko) | 2012-09-03 | 2015-05-11 | 에쏘세아 파르밍 에쎄.아. | 수생 생물종의 배향 및／또는 억제를 위한 저장조 케이지 침지 시스템 |
| SI2911623T1 (sl) | 2012-10-26 | 2019-12-31 | Forsight Vision5, Inc. | Oftalmični sistem za podaljšano sproščanje zdravila v oko |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| MX2015014199A (es) | 2013-04-10 | 2016-06-21 | Preglem Sa | Moduladores del receptor de progesterona para usarse en la terapia de fibromas uterinos. |
| US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
| CA3208334A1 (en) * | 2014-04-01 | 2015-10-08 | Poly-Med, Inc. | Contraceptive and related device |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| ES2728504T3 (es) | 2014-06-26 | 2019-10-25 | Taris Biomedical Llc | Dispositivos de administración de fármacos por vía intravesical y métodos que comprenden sistemas matriciales polímero-fármaco elásticos |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| CN110403565B (zh) * | 2018-04-27 | 2022-02-11 | 西安交通大学医学院第一附属医院 | 一种胶囊内窥镜磁与麦芒仿生双驱动装置 |
| CN109771124A (zh) * | 2019-01-31 | 2019-05-21 | 山东省药学科学院 | 一种具有形状记忆功能的子宫托 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3545439A (en) | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
| US3920805A (en) | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
| US4012496A (en) | 1974-10-18 | 1977-03-15 | Schering Aktiengesellschaft | Vaginal ring |
| US4292965A (en) | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
| US4596576A (en) | 1984-10-12 | 1986-06-24 | Akzo N.V. | Release system for two or more active substances |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1264731A (en) * | 1917-03-19 | 1918-04-30 | Carl Willers | Pneumatic die-cushion. |
| US3967618A (en) * | 1969-04-01 | 1976-07-06 | Alza Corporation | Drug delivery device |
| US3911911A (en) * | 1969-06-16 | 1975-10-14 | Reese Hospital Michael | Anti-fertility device |
| GB1465684A (en) * | 1973-07-27 | 1977-02-23 | Emmett L | Contraceptive device |
| DE2616064A1 (de) * | 1976-04-09 | 1977-10-20 | Schering Ag | Vaginalring iii |
| US3995634A (en) * | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal cavity dispensing means and method |
| US4215691A (en) * | 1978-10-11 | 1980-08-05 | Alza Corporation | Vaginal contraceptive system made from block copolymer |
| DE3040978A1 (de) * | 1980-10-28 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Vaginalring |
| ATE21331T1 (de) * | 1981-12-30 | 1986-08-15 | Population Council Inc | Verfahren zur herstellung von intrauterinen vorrichtungen. |
| JPS5919151U (ja) * | 1982-07-28 | 1984-02-06 | ニツポ−株式会社 | 痔疾治療器 |
| GB8403138D0 (en) * | 1984-02-07 | 1984-03-14 | Graham N B | Sustained release of active ingredient |
| ZA857643B (en) * | 1984-10-12 | 1986-05-28 | Akzo Nv | Release system for two or more active substances |
| SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
| US4822161A (en) * | 1988-01-19 | 1989-04-18 | Jimmy Michael F | Illuminating spectacle apparatus |
| JPH02185264A (ja) * | 1988-12-16 | 1990-07-19 | Ferring Bv | 膀胱内又は尿管へ薬を送り込む方法及び装置 |
| KR100236355B1 (ko) * | 1990-03-16 | 2000-01-15 | 이데이 노부유끼 | 와이프 패턴의 발생장치 |
| JP3186105B2 (ja) * | 1991-07-26 | 2001-07-11 | 日本電気株式会社 | 半導体装置のテストモード設定・解除回路 |
| FI95768C (fi) * | 1993-06-17 | 1996-03-25 | Leiras Oy | Emättimensisäinen antosysteemi |
-
1993
- 1993-06-17 FI FI932789A patent/FI95768C/fi active
-
1994
- 1994-06-15 DK DK94917022T patent/DK0703802T3/da active
- 1994-06-15 DE DE69417232T patent/DE69417232T2/de not_active Expired - Lifetime
- 1994-06-15 HU HU9503290A patent/HU217950B/hu not_active IP Right Cessation
- 1994-06-15 ES ES94917022T patent/ES2130423T3/es not_active Expired - Lifetime
- 1994-06-15 MY MYPI94001519A patent/MY113965A/en unknown
- 1994-06-15 AT AT94917022T patent/ATE177657T1/de not_active IP Right Cessation
- 1994-06-15 WO PCT/FI1994/000255 patent/WO1995000199A1/en not_active Ceased
- 1994-06-15 JP JP52252194A patent/JP3803714B2/ja not_active Expired - Fee Related
- 1994-06-15 EP EP94917022A patent/EP0703802B1/en not_active Expired - Lifetime
- 1994-06-15 RU RU96101160A patent/RU2121824C1/ru not_active IP Right Cessation
- 1994-06-15 TW TW083105534A patent/TW286273B/zh not_active IP Right Cessation
- 1994-06-15 PL PL94312193A patent/PL176664B1/pl not_active IP Right Cessation
- 1994-06-15 KR KR1019950705668A patent/KR100312764B1/ko not_active Expired - Fee Related
- 1994-06-15 AU AU68481/94A patent/AU674758B2/en not_active Ceased
- 1994-06-15 BR BR9407118A patent/BR9407118A/pt not_active IP Right Cessation
- 1994-06-15 CZ CZ953208A patent/CZ284989B6/cs not_active IP Right Cessation
- 1994-06-15 CN CN94192420A patent/CN1126574C/zh not_active Expired - Fee Related
- 1994-06-15 US US08/564,253 patent/US5694947A/en not_active Expired - Lifetime
- 1994-06-16 LT LTIP1957A patent/LT3455B/lt not_active IP Right Cessation
- 1994-07-18 EE EE9400027A patent/EE03202B1/xx not_active IP Right Cessation
-
1995
- 1995-12-12 NO NO19955029A patent/NO311498B1/no not_active IP Right Cessation
-
1999
- 1999-06-17 GR GR990401648T patent/GR3030565T3/el unknown
- 1999-12-01 LV LVP-99-169A patent/LV12452B/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3545439A (en) | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
| US3920805A (en) | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
| US4012496A (en) | 1974-10-18 | 1977-03-15 | Schering Aktiengesellschaft | Vaginal ring |
| US4292965A (en) | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
| US4596576A (en) | 1984-10-12 | 1986-06-24 | Akzo N.V. | Release system for two or more active substances |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3455B (en) | Intravaginal delivery system of active agent | |
| ES2160675T3 (es) | Dispositivo implantable debajo de la dermis. | |
| KR100492676B1 (ko) | 2종이상의활성물질을위한약물전달시스템 | |
| US3765414A (en) | Drug release system | |
| CA2573266C (en) | Sustained release compositions containing progesterone receptor modulators | |
| RU96101160A (ru) | Внутривлагалищная система доставки | |
| AU4043197A (en) | Intravaginal rings with insertable drug-containing core | |
| PT97441B (pt) | Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral | |
| EP1003448B1 (en) | Condoms with improved security | |
| EP0016051A1 (en) | Contraceptive-antivenereal disease tampon | |
| TW201043208A (en) | Vaginal delivery system | |
| CA2165282C (en) | Intravaginal delivery system | |
| US20230404910A1 (en) | Implantable cannabis transdermal | |
| MXPA06000428A (en) | Intravaginal drug delivery devices |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM9A | Lapsed patents |
Effective date: 20110616 |